NCT02086201

Brief Summary

This is a non-inferiority trial of Engage, a new intervention for late-life depression, and problem solving therapy (PST). Patient participants will be randomized to either Engage or PST and receive 9 weeks of either intervention. Interview assessments will be collected at baseline and weeks 2, 4, 6, 8, 9, 26, and 36. Clinician participants, social workers from mental health agencies, will be randomized to receive training and certification in either Engage or PST.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
262

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2014

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 13, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2014

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2020

Completed
Last Updated

June 29, 2021

Status Verified

June 1, 2021

Enrollment Period

5.9 years

First QC Date

February 25, 2014

Last Update Submit

June 25, 2021

Conditions

Keywords

major depressiondepressiondepressive disordermental healthmental disorder

Outcome Measures

Primary Outcomes (1)

  • Depression

    Depression will be assessed using the Hamilton Depression Rating Scale, a multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.

    Measured at pretreatment and weeks 2,4,6,8,9,26 and 36

Study Arms (2)

Problem Solving Therapy

ACTIVE COMPARATOR

Problem solving therapy is an evidence based psychotherapy for depression, with 30 years of research supporting its efficacy. PST focuses on the patients themselves and helps them develop skills in identifying, prioritizing, and solving problems, and thereby creates a sense of empowerment.

Behavioral: Problem Solving Therapy

Engage

EXPERIMENTAL

Engage utilizes reward exposure consisting of the reintroduction of activities that patients once found rewarding and enjoyed, but have abandoned after they developed depression. Engage uses basic problem solving through which patients learn how to form "action plans" for pursuing rewarding activities of their choice.

Behavioral: Engage

Interventions

PST is a behavioral intervention for depression that is delivered by trained therapists over a 9 week period. It consists of a process to help patients understand and then solve the problems in their lives they feel is contributing to their depression.

Problem Solving Therapy
EngageBEHAVIORAL

Engage is a weekly behavioral intervention that is delivered over a 9 week period of time by trained therapists. The focus of Engage is to help patient reconnect with activities that they have lost interest in pursuing due to depression.

Engage

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 60 years
  • unipolar, non-psychotic major depression (by SCID, DSM-IV)
  • MADRS ≥ 20
  • MMSE ≥ 24
  • off antidepressants or have been on a stable dose of an antidepressant for 12 weeks and do not intend to change the dose in the next 10 weeks
  • English speaking
  • capacity to provide written consent

You may not qualify if:

  • Presence of psychiatric diagnoses other than unipolar, non-psychotic major depression or generalized anxiety disorder
  • Newly started use of psychotropic drugs (\<12wks) or cholinesterase inhibitors other than mild doses of benzodiazepines
  • Current active suicidal intent/plan
  • Current substance abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Weill Medical College of Cornell University

White Plains, New York, 10605, United States

Location

University of Washington Department of Psychiatry and Behavioral Sciences

Seattle, Washington, 98195, United States

Location

MeSH Terms

Conditions

Depressive Disorder, MajorDepressionDepressive DisorderPsychological Well-BeingMental Disorders

Interventions

engage 8200

Condition Hierarchy (Ancestors)

Mood DisordersBehavioral SymptomsBehaviorPersonal Satisfaction

Study Officials

  • Patricia Arean, PhD

    UW

    PRINCIPAL INVESTIGATOR
  • George Alexopoulos, M.D.

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Psychiatry and Behavioral Sciences

Study Record Dates

First Submitted

February 25, 2014

First Posted

March 13, 2014

Study Start

May 1, 2014

Primary Completion

March 31, 2020

Study Completion

March 31, 2020

Last Updated

June 29, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will share

We intend to share de-identified data once study is complete

Locations